Sara M. Karaba

494 total citations
16 papers, 355 citations indexed

About

Sara M. Karaba is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, Sara M. Karaba has authored 16 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Applied Microbiology and Biotechnology and 4 papers in Infectious Diseases. Recurrent topics in Sara M. Karaba's work include Antibiotic Use and Resistance (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Infections and bacterial resistance (4 papers). Sara M. Karaba is often cited by papers focused on Antibiotic Use and Resistance (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Infections and bacterial resistance (4 papers). Sara M. Karaba collaborates with scholars based in United States. Sara M. Karaba's co-authors include Nicholas P. Cianciotto, Sara E. Cosgrove, Joe Amoah, Richard C. White, Ashley Dumont, Kathryn Dzintars, Valeria Fabre, Benjamin J. Koestler, Pranita D. Tamma and Lauren E. Bellows and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Sara M. Karaba

15 papers receiving 354 citations

Peers

Sara M. Karaba

ENDOC

AMB

EPIDE

Rachael K. Jacobson South Africa

Emese Juhász Hungary

Typhaine Billard‐Pomares France

Omid Pajand Iran

Joshi Acosta Spain

Ivan Palagin Russia

Xiaohua Qin China

A.L. Barth Brazil

Xiuyu Xu China

Anne Dubouix France

Rachael K. Jacobson South Africa

Sara M. Karaba

119 ×0.8

ENDOC

102 ×0.9

37 ×0.4

AMB

113 ×1.2

EPIDE

123 ×1.7

Citations per year, relative to Sara M. Karaba Sara M. Karaba (= 1×) peers Rachael K. Jacobson

Countries citing papers authored by Sara M. Karaba

Since Specialization

Citations

This map shows the geographic impact of Sara M. Karaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara M. Karaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara M. Karaba more than expected).

Fields of papers citing papers by Sara M. Karaba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara M. Karaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara M. Karaba. The network helps show where Sara M. Karaba may publish in the future.

Co-authorship network of co-authors of Sara M. Karaba

This figure shows the co-authorship network connecting the top 25 collaborators of Sara M. Karaba. A scholar is included among the top collaborators of Sara M. Karaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara M. Karaba. Sara M. Karaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Karaba, Sara M., Yehudit Bergman, Jae Hyoung Lee, et al.. (2025). 314. Ceftazidime-Avibactam Versus Meropenem-Vaborbactam for the Treatment of Carbapenem-Resistant Enterobacterales Infections. Open Forum Infectious Diseases. 12(Supplement_1).

Cosgrove, Sara E., Robert A. Bonomo, Kathryn Dzintars, et al.. (2024). Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam. Antimicrobial Agents and Chemotherapy. 68(10). e0090724–e0090724. 7 indexed citations

Tamma, Pranita D., Sara M. Karaba, Tsigereda Tekle, et al.. (2024). Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam. Clinical Infectious Diseases. 79(4). 819–825. 11 indexed citations

Karaba, Sara M., Sara E. Cosgrove, Jae Hyoung Lee, et al.. (2024). Extended-Infusion β-Lactam Therapy, Mortality, and Subsequent Antibiotic Resistance Among Hospitalized Adults With Gram-Negative Bloodstream Infections. JAMA Network Open. 7(7). e2418234–e2418234. 6 indexed citations

Morris, C. Paul, Stuart C. Ray, Sara E. Cosgrove, et al.. (2022). Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure investigations using genomic sequencing among healthcare workers and patients in a large academic center. Infection Control and Hospital Epidemiology. 44(5). 798–801. 2 indexed citations

Queen, Jessica, Sara M. Karaba, John S. Albin, et al.. (2021). The Time is Now: A Call for Renewed Support of Infectious Diseases Physician-Scientist Trainees in the Era of Coronavirus Disease 2019. The Journal of Infectious Diseases. 224(9). 1452–1454. 1 indexed citations

Tamma, Pranita D., Sara M. Karaba, Emily Jacobs, et al.. (2021). Prevalence of bla _CTX-M Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States. Journal of Clinical Microbiology. 59(6). 32 indexed citations

Karaba, Sara M., Joe Amoah, Robin K. Avery, et al.. (2021). Hospital-acquired infections among adult patients admitted for coronavirus disease 2019 (COVID-19). Infection Control and Hospital Epidemiology. 43(8). 1054–1057. 19 indexed citations

Fabre, Valeria, Sara M. Karaba, Joe Amoah, et al.. (2021). The role of procalcitonin results in antibiotic decision-making in coronavirus disease 2019 (COVID-19). Infection Control and Hospital Epidemiology. 43(5). 570–575. 22 indexed citations

10.

Karaba, Sara M., Katherine E Goodman, Joe Amoah, Sara E. Cosgrove, & Pranita D. Tamma. (2021). StenoSCORE: Predicting Stenotrophomonas maltophilia Bloodstream Infections in the Hematologic Malignancy Population. Antimicrobial Agents and Chemotherapy. 65(8). e0079321–e0079321. 20 indexed citations

11.

Cosgrove, Sara E., Valeria Fabre, Sara M. Karaba, et al.. (2021). Impact of weekly asymptomatic testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in inpatients at an academic hospital. Infection Control and Hospital Epidemiology. 44(1). 99–101. 5 indexed citations

12.

Karaba, Sara M., Robin K. Avery, Kathryn Dzintars, et al.. (2020). Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study. Open Forum Infectious Diseases. 8(1). ofaa578–ofaa578. 85 indexed citations

13.

Dumont, Ashley, Sara M. Karaba, & Nicholas P. Cianciotto. (2015). Type II Secretion-Dependent Degradative and Cytotoxic Activities Mediated by Stenotrophomonas maltophilia Serine Proteases StmPr1 and StmPr2. Infection and Immunity. 83(10). 3825–3837. 35 indexed citations

14.

Karaba, Sara M., Richard C. White, & Nicholas P. Cianciotto. (2013). Stenotrophomonas maltophilia Encodes a Type II Protein Secretion System That Promotes Detrimental Effects on Lung Epithelial Cells. Infection and Immunity. 81(9). 3210–3219. 38 indexed citations

15.

Bellows, Lauren E., Benjamin J. Koestler, Sara M. Karaba, Christopher M. Waters, & Wyndham W. Lathem. (2012). Hfq‐dependent, co‐ordinate control of cyclic diguanylate synthesis and catabolism in the plague pathogen Yersinia pestis. Molecular Microbiology. 86(3). 661–674. 51 indexed citations

16.

Karaba, Sara M., et al.. (2011). Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degrees. Microbiology. 157(7). 2133–2142. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact